Equity Details
Price & Market Data
Price: $19.20
Daily Change: -$0.86 / 4.48%
Daily Range: $18.85 - $22.50
Market Cap: $1,323,150,464
Daily Volume: 387,405
Performance Metrics
1 Week: -6.04%
1 Month: -17.96%
3 Months: -10.21%
6 Months: -10.21%
1 Year: -10.21%
YTD: -10.21%
About Alamar Biosciences, Inc. (ALMR)
Comprehensive analysis of Alamar Biosciences, Inc. (ALMR). Currently at 19.20, with a daily change of -$0.86 / 4.48%. Market cap: 1,323,150,464. Evaluate its performance over YTD, 1-month, and 6-month periods.
Company Details
Employees: 222
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. The company was incorporated in 2018 and is based in Fremont, California.
